NCT07590596Not yet recruiting
Preoperative Decision-Making in Patients With Pulmonary Nodules Suspected of Lung Cancer
Preoperative Decision-Making Characteristics and Associated Mechanisms in Patients With Pulmonary Nodules Suspected of Lung Cancer
Source: ClinicalTrials.gov · Last updated 18 May 2026
Brief summary (registry, in English)
Patients with pulmonary nodules that are highly suspected to be lung cancer often need to make important treatment decisions before a definite pathological diagnosis is available. These decisions may include whether to undergo surgery, whether to continue follow-up, whether to have further diagnostic tests, and how to understand the potential benefits and risks of different management options. This prospective observational study aims to describe the preoperative decision-making status of adult patients with pulmonary nodules suspected of lung cancer. The study will assess patients' decision self-efficacy, decisional conflict, shared decision-making experience, and decision regret using standardized questionnaires. It will also explore factors associated with better or worse decision quality, such as demographic characteristics, clinical information, health literacy, doctor-patient communication, family involvement, and emotional status. No treatment or intervention will be assigned by the study. Participants will receive routine clinical care, and study data will be collected mainly through questionnaires before surgery or during the preoperative period. The findings may help clinicians identify patients who need additional decision support and improve communication during preoperative decision-making for suspected lung cancer.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 10 May 2026
- Start date
- May 2026
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Sichuan Cancer Hospital and Research Institute
- Diseases
- Lung cancer
- NCT number
- NCT07590596
What you commit to
- Study type: Observational
- Planned participants: 200
- From May 2026 to the primary completion date, 30 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with severe cognitive impairment or a history of severe psychiatric disease that would interfere with valid questionnaire completion.
Other
- Patients without a real clinical decision-making choice regarding the management of the pulmonary nodule.
- Patients who are unable to communicate effectively with the study staff.
- Patients who decline to participate or are unable to provide written informed consent.
Who the study is looking for
- Age 18 years or older.
- Adult patients with pulmonary nodules that are highly suspected of malignancy based on clinical and radiological assessment.
- No definite pathological diagnosis of lung cancer before enrollment.
- Patients who are facing preoperative clinical decision-making with more than one reasonable management option, such as surgery, additional diagnostic evaluation, or follow-up.
- Able to understand the study procedures and complete the study questionnaires.
- Able and willing to provide written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China Coordinator of this site? Confirm its status | Chengdu | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.